Company Performance Metrics
Wise Diagnostic Systems operates a medical diagnostics laboratory under the Wise Dx brand, focusing on molecular testing for infectious diseases and pharmacogenomics. The company uses PCR-based platforms to detect targeted pathogens and antibiotic resistance genes, providing higher sensitivity and specificity than culture methods. Its test menu
includes dedicated panels for urinary tract infections, wound infections, respiratory pathogens including SARS-CoV-2, and gastrointestinal pathogens, along with pharmacogenomic assays that assess genetic variants affecting drug metabolism. Wise Diagnostic Systems serves clinicians in settings such as nursing homes, long-term care, gastroenterology practices, and infectious disease clinics. Reports include supplemental interpretive matrices summarizing likely treatment options, cost considerations, and antibiotic classes to avoid based on genetic resistance. Specimens are transported via overnight services and local couriers, and results are typically delivered in less than 24 hours.
